keyword
https://read.qxmd.com/read/38616658/a-path-to-persistence-after-egfr-inhibition
#1
JOURNAL ARTICLE
Purva H Rumde, Timothy F Burns
Residual cancer cells persist even after targeted therapies, serving as a reservoir for the subsequent acquisition of genetic alterations that lead to acquired drug resistance and tumor relapse. These initial drug-tolerant persisters (DTP) are phenotypically heterogenous with transient phenotypes attributed to epigenetic, metabolic, and cell-cycle changes. DTPs are responsible for the inevitable relapse seen in EGFR-mutant non-small cell lung cancer (NSCLC) despite high initial response to tyrosine kinase inhibitor (TKI) treatment...
April 15, 2024: Cancer Research
https://read.qxmd.com/read/38616212/systematic-review-article-new-drug-strategies-for-treating-resistant-hypertension-the-importance-of-a-mechanistic-personalized-approach
#2
REVIEW
Giulia Nardoianni, Barbara Pala, Alessandra Scoccia, Massimo Volpe, Emanuele Barbato, Giuliano Tocci
Resistant hypertension (RHT) is characterized by persistently high blood pressure (BP) levels above the widely recommended therapeutic targets of less than 140/90 mmHg office BP, despite life-style measures and optimal medical therapies, including at least three antihypertensive drug classes at maximum tolerated dose (one should be a diuretic). This condition is strongly related to hypertension-mediated organ damage and, mostly, high risk of hospitalization due to hypertension emergencies or acute cardiovascular events...
April 14, 2024: High Blood Pressure & Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension
https://read.qxmd.com/read/38616015/mesenchymal-stem-cell-transplantation-may-be-able-to-induce-immunological-tolerance-in-systemic-lupus-erythematosus
#3
JOURNAL ARTICLE
Julia Barbado
Systemic lupus erythematosus (SLE) is a common, potentially fatal autoimmune disease involving a significant inflammatory response. SLE is characterised by failure of self-tolerance and activation of autoreactive lymphocytes, leading to persistent disease. Although current treatments achieve some improvement in patients, some SLE patients are refractory and others relapse after drug withdrawal. The toxicity of current drug regimens, with recurrent infections, together with ongoing inflammation, contribute significantly to the progressive decline in organ function...
April 12, 2024: Biomedical Journal
https://read.qxmd.com/read/38615798/ultramicronized-n-palmitoylethanolamine-associated-with-analgesics-effects-against-persistent-pain
#4
REVIEW
Stefania Nobili, Laura Micheli, Elena Lucarini, Alessandra Toti, Carla Ghelardini, Lorenzo Di Cesare Mannelli
Current epidemiological data estimate that one in five people suffers from chronic pain with considerable impairment of health-related quality of life. The pharmacological treatment is based on first- and second-line analgesic drugs, including COX-2 selective and nonselective nonsteroidal anti-inflammatory drugs, paracetamol, antidepressants, anti-seizure drugs and opioids, that are characterized by important side effects. N-palmitoylethanolamine (PEA) is a body's own fatty-acid ethanolamide belonging to the family of autacoid local injury antagonist amides...
April 12, 2024: Pharmacology & Therapeutics
https://read.qxmd.com/read/38615093/tafamidis-61%C3%A2-mg-patient-characteristics-and-persistency-a-retrospective-analysis-of-german-statutory-health-insurance-data-iqvia%C3%A2-lrx
#5
JOURNAL ARTICLE
Sepideh Attal, Jason Kemner, Jose Alvir, Sebastian Barth, Sofia Schuessler
INTRODUCTION: Tafamidis is the first drug approved by the European Commission for the treatment of wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization. Real-world treatment patterns of tafamidis 61 mg in Germany are not well studied in patients with ATTR-CM. METHODS: This was a non-interventional, retrospective, observational cohort study of adult patients in Germany based on the IQVIA pharmacy claims database (IQVIA™ LRx)...
April 13, 2024: Cardiology and Therapy
https://read.qxmd.com/read/38608858/membraneless-and-membrane-bound-organelles-in-an-anhydrobiotic-cell-line-are-protected-from-desiccation-induced-damage
#6
JOURNAL ARTICLE
Clinton J Belott, Oleg A Gusev, Takahiro Kikawada, Michael A Menze
Anhydrobiotic species can survive virtually complete water loss by entering a reversible ametabolic glassy state that may persist for years in ambient conditions. The Pv11 cell line was derived from egg mass of the anhydrobiotic midge, Polypedilum vanderplanki, and is currently the only available anhydrobiotic cell line. Our results demonstrate that the necessary preconditioning for Pv11 cells to enter anhydrobiosis causes autophagy and reduces mitochondrial respiration by over 70%. We speculate that reorganizing cellular bioenergetics to create and conserve energy stores may be valuable to successfully recover after rehydration...
April 10, 2024: Cell Stress & Chaperones
https://read.qxmd.com/read/38608652/leflunomide-with-prednisone-or-nonsteroidal-anti-inflammatory-drug-therapy-is-safe-and-tolerated-for-long-term-treatment-of-immune-mediated-polyarthritis-in-27-dogs
#7
JOURNAL ARTICLE
Rebecca B Chesne, Michael T Doornink, Loren S H Sri-Jayantha, Bridget K Urie
OBJECTIVE: To retrospectively evaluate safety and tolerance of leflunomide for long-term treatment of canine idiopathic immune-mediated polyarthritis (IMPA). ANIMALS: 27 dogs with clinical signs and synovial fluid cytology supportive of IMPA with ≥ 6 months' follow-up after starting leflunomide. METHODS: Medical records were reviewed to identify dogs prescribed leflunomide for treatment of IMPA from February 2012 to May 2022. Initial leflunomide doses of 2 to 4 mg/kg once daily were prescribed and were titrated to the lowest effective dose with concurrent anti-inflammatory therapy...
April 12, 2024: Journal of the American Veterinary Medical Association
https://read.qxmd.com/read/38602032/hypoglossal-nerve-stimulation-for-obstructive-sleep-apnea-in-a-young-child-with-down-syndrome
#8
JOURNAL ARTICLE
Isaac Wasserman, Douglas J Chieffe, Kevin S Gipson, Brian G Skotko, Christopher J Hartnick
Obstructive sleep apnea (OSA) is common in children with Down syndrome (DS). Adenoidectomy and/or tonsillectomy are the usual first interventions employed to treat OSA in children with DS but sometimes do not achieve adequate resolution of clinical signs. Positive airway pressure treatment is often used next, but this treatment is poorly tolerated by this population. Persistent OSA can adversely affect a child's health and cognitive development. Hypoglossal nerve stimulation (HGNS), previously shown to be safe and effective in adults with OSA, has been used in children as young as 10 years old with DS and has achieved measurable neurocognitive benefits...
April 11, 2024: Pediatrics
https://read.qxmd.com/read/38598345/pharmacological-expansion-of-type-2-alveolar-epithelial-cells-promotes-regenerative-lower-airway-repair
#9
JOURNAL ARTICLE
Sida Shao, Nan Zhang, Gregory P Specht, Shaochen You, Lirui Song, Qiangwei Fu, David Huang, Hengyao You, Jian Shu, Alain Domissy, Shuangwei Li, Van Nguyen-Tran, Sean B Joseph, Arnab K Chatterjee, Jeffrey Jian Chen, Peter G Schultz, Michael J Bollong
Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to lower airway repair. Agents that promote the selective expansion of these cells might stimulate regeneration of the compromised alveolar epithelium, an etiology-defining event in several pulmonary diseases. From a high-content imaging screen of the drug repurposing library ReFRAME, we identified that dipeptidyl peptidase 4 (DPP4) inhibitors, widely used type 2 diabetes medications, selectively expand AEC2s and are broadly efficacious in several mouse models of lung damage...
April 16, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38594459/utility-of-accessible-sars-cov-2-specific-immunoassays-in-vaccinated-adults-with-a-history-of-advanced-hiv-infection
#10
JOURNAL ARTICLE
Ludovica Ferrari, Alessandra Ruggiero, Chiara Stefani, Livia Benedetti, Lorenzo Piermatteo, Eleonora Andreassi, Federica Caldara, Drieda Zace, Matteo Pagliari, Francesca Ceccherini-Silberstein, Christopher Jones, Marco Iannetta, Anna Maria Geretti
Accessible SARS-CoV-2-specific immunoassays may inform clinical management in people with HIV, particularly in case of persisting immunodysfunction. We prospectively studied their application in vaccine recipients with HIV, purposely including participants with a history of advanced HIV infection. Participants received one (n = 250), two (n = 249) or three (n = 42) doses of the BNT162b2 vaccine. Adverse events were documented through questionnaires. Sample collection occurred pre-vaccination and a median of 4 weeks post-second dose and 14 weeks post-third dose...
April 9, 2024: Scientific Reports
https://read.qxmd.com/read/38583092/plozasiran-aro-apoc3-for-severe-hypertriglyceridemia-the-shasta-2-randomized-clinical-trial
#11
JOURNAL ARTICLE
Daniel Gaudet, Denes Pall, Gerald F Watts, Stephen J Nicholls, Robert S Rosenson, Karen Modesto, Javier San Martin, Jennifer Hellawell, Christie M Ballantyne
IMPORTANCE: Severe hypertriglyceridemia (sHTG) confers increased risk of atherosclerotic cardiovascular disease (ASCVD), nonalcoholic steatohepatitis, and acute pancreatitis. Despite available treatments, persistent ASCVD and acute pancreatitis-associated morbidity from sHTG remains. OBJECTIVE: To determine the tolerability, efficacy, and dose of plozasiran, an APOC3-targeted small interfering-RNA (siRNA) drug, for lowering triglyceride and apolipoprotein C3 (APOC3, regulator of triglyceride metabolism) levels and evaluate its effects on other lipid parameters in patients with sHTG...
April 7, 2024: JAMA Cardiology
https://read.qxmd.com/read/38582275/continuous-oral-olanzapine-or-clozapine-treatment-initiated-in-adolescence-has-differential-short-and-long-term-impacts-on-antipsychotic-sensitivity-than-those-initiated-in-adulthood
#12
JOURNAL ARTICLE
Ruiyong Wu, Shinnyi Chou, Ming Li
One of the major discoveries in recent research on antipsychotic drugs is that antipsychotic treatment in adolescence could induce robust long-term alterations in antipsychotic sensitivity that persist into adulthood. These long-term impacts are likely influenced by various factors, including the "diseased" state of animals, sex, type of drugs, mode of drug administration, and age of treatment onset. In this study we compared the short- and long-term behavioral effects of 21-day continuous oral olanzapine (7...
April 4, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38569982/pharmacological-agents-targeting-drug-tolerant-persister-cells-in-cancer
#13
REVIEW
Yu-Chi Chen, Krishna Gowda, Shantu Amin, Todd D Schell, Arun K Sharma, Gavin P Robertson
Current cancer therapy can be effective, but the development of drug resistant disease is the usual outcome. These drugs can eliminate most of the tumor burden but often fail to eliminate the rare, "Drug Tolerant Persister" (DTP) cell subpopulations in residual tumors, which can be referred to as "Persister" cells. Therefore, novel therapeutic agents specifically targeting or preventing the development of drug-resistant tumors mediated by the remaining persister cells subpopulations are needed. Since approximately ninety percent of cancer-related deaths occur because of the eventual development of drug resistance, identifying, and dissecting the biology of the persister cells is essential for the creation of drugs to target them...
April 1, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38560514/a-real-world-multicenter-study-on-left-atrial-appendage-occlusion-the-italian-multi-device-experience
#14
JOURNAL ARTICLE
Antonio Procopio, Francesco Radico, Felice Gragnano, Chiara Ghiglieno, Gaetano Fassini, Annalisa Filtz, Alessandro Barbarossa, Daniele Sacchetta, Massimiliano Faustino, Fabrizio Ricci, Antonio Dello Russo, Paolo Calabrò, Giuseppe Patti, Sabina Gallina, Giulia Renda
BACKGROUND: Transcatheter left atrial appendage occlusion (LAAO) has emerged as an alternative treatment for stroke prevention in patients with atrial fibrillation (AF) at high risk of thromboembolism, who cannot tolerate long-term oral anticoagulation (OAC). Questions persist regarding effectiveness and safety of this treatment and the optimal post-interventional antithrombotic regimen after LAAO. METHODS: We retrospectively gathered data from 428 patients who underwent percutaneous LAAO in 6 Italian high-volume centres, aimed at describing the real-world utilization, safety, and effectiveness of LAAO procedures, also assessing the clinical outcomes associated with different antithrombotic strategies...
April 2024: IJC Heart & Vasculature
https://read.qxmd.com/read/38551790/dusp1-promotes-osimertinib-drug-tolerant-persistence-by-inhibiting-mapk-erk-signaling-in-non-small-cell-lung-cancer
#15
JOURNAL ARTICLE
Wenjuan He, Ping Liu, Quan Lei, Jun Xu, Li Liu
EGFR tyrosine kinase inhibitors (EGFR-TKIs) are the first-line treatment for EGFR-mutant non-small cell lung cancer (NSCLC) patients, which remarkably improve the clinical outcomes. However, drug resistance has greatly impaired the efficacy of EGFR-TKIs and contributes to cancer treatment failure. DUSP1, a negative regulator of MAPK signaling pathway, was discovered to mediate drug resistance in multiple types of cancers. Our study aimed to explore the role of DUSP1 in NSCLC cell resistance to osimertinib, a third-generation EGFR-TKI...
March 29, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38534663/polylactic-glycolic-acid-mediated-delivery-of-plectasin-derivative-nz2114-in-staphylococcus-epidermidis-biofilms
#16
JOURNAL ARTICLE
Xuanxuan Ma, Na Yang, Ruoyu Mao, Ya Hao, Da Teng, Yinhua Huang, Jianhua Wang
Antimicrobial peptides (AMPs) are antibiotic candidates; however, their instability and protease susceptibility limit clinical applications. In this study, the polylactic acid-glycolic acid (PLGA)-polyvinyl alcohol (PVA) drug delivery system was screened by orthogonal design using the double emulsion-solvent evaporation method. NZ2114 nanoparticles (NZ2114-NPs) displayed favorable physicochemical properties with a particle size of 178.11 ± 5.23 nm, polydispersity index (PDI) of 0.108 ± 0.10, ζ potential of 4...
February 29, 2024: Antibiotics
https://read.qxmd.com/read/38528476/long-term-treatment-with-lasmiditan-in-patients-with-migraine-post-hoc-analysis-of-treatment-patterns-and-outcomes-from-the-open-label-extension-of-the-centurion-randomized-trial
#17
RANDOMIZED CONTROLLED TRIAL
Mika Komori, Akichika Ozeki, Yuka Tanji, Eriko Kamiki, John H Krege, Lily Qian Li, Shiho Suzuki, Mamoru Shibata, Takao Takeshima
BACKGROUND: The objective of this analysis was to gain new insights into the patient characteristics and other factors associated with lasmiditan usage and clinical outcomes under conditions resembling the real-world setting. METHODS: This was a post hoc analysis of data from the 12-month, open-label extension (OLE) of the phase 3, double-blind, randomized, controlled CENTURION trial, which examined the efficacy and safety of lasmiditan as acute treatment across four migraine attacks...
March 25, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38527614/the-impact-of-the-fluconazole-trailing-effect-on-the-persistence-of-candida-albicans-bloodstream-infection-when-treated-with-fluconazole
#18
JOURNAL ARTICLE
Shang-Yi Lin, Ho-Yin Huang, Lin-Li Chang, Ya-Ling Wang, Tun-Chieh Chen, Ko Chang, Hung-Pin Tu, Po-Liang Lu
OBJECTIVES: The trailing effect of Candida species is a phenomenon characterized by reduced but persistent growth at antifungal concentrations above the minimal inhibitory concentration (MIC). We assessed the impact of trailing growth on the persistence of Candida albicans candidemia in patients receiving fluconazole therapy. METHODS: We retrospectively investigated candidemia isolates at three hospitals in southern Taiwan between 2013 and 2020. Patients treated with fluconazole for fluconazole-susceptible C...
March 23, 2024: Clinical Microbiology and Infection
https://read.qxmd.com/read/38525093/nivolumab-safety-in-renal-cell-carcinoma-a-case-report
#19
James Debono, Dustin Balzan, John Joseph Borg, Stephen Falzon, Dania Al-Haddad, Benjamin Micallef, Janet Sultana
Nivolumab is used to treat several different types of cancers. Although it is generally considered to be effective and well-tolerated, it has been associated with adverse effects requiring discontinuation of treatment, like many other drugs used for cancer. A 70-year-old male was switched from sunitinib to nivolumab for renal cell carcinoma. The patient developed persistent hypothyroidism, onycholysis, and pneumonitis at nivolumab cycle 6, 10, and 11, respectively. Using the Naranjo causality method, the likelihood of causality was deemed "probable" for pneumonitis and hypothyroidism and "possible" for onycholysis...
April 2024: Journal of Pharmacy Technology: JPT: Official Publication of the Association of Pharmacy Technicians
https://read.qxmd.com/read/38524205/gestational-diabetes-mellitus-in-pregnancies-conceived-after-infertility-treatment-a-population-based-study-in-the-united-states-2015-2020
#20
JOURNAL ARTICLE
Devika Sachdev, Mark V Sauer, Cande V Ananth
OBJECTIVE: To evaluate the risk of gestational diabetes mellitus (GDM) in singleton pregnancies conceived using infertility treatment and examine the influence of race and ethnicity as well as prepregnancy body mass index (BMI). DESIGN: Cross-sectional study using the US vital records data of women that delivered singleton births. SETTING: United States, 2015-2020. INTERVENTIONS: Any infertility treatment was divided into two groups: those that used fertility-enhancing drugs, artificial insemination, or intrauterine insemination, and those that used assisted reproductive technology (ART)...
March 2024: F&S reports
keyword
keyword
22278
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.